-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Syndax Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Syndax Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$84.1M, a 64.5% decline year-over-year.
- Syndax Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$297M, a 68.7% decline year-over-year.
- Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$209M, a 40.2% decline from 2022.
- Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$149M, a 699% decline from 2021.
- Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was $24.9M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)